These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23529936)

  • 1. Planning multi-arm screening studies within the context of a drug development program.
    Wason JM; Jaki T; Stallard N
    Stat Med; 2013 Sep; 32(20):3424-35. PubMed ID: 23529936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal design of multi-arm multi-stage trials.
    Wason JM; Jaki T
    Stat Med; 2012 Dec; 31(30):4269-79. PubMed ID: 22826199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptive Designs with Discrete Test Statistics and Consideration of Overrunning.
    Schmidt R; Burkhardt B; Faldum A
    Methods Inf Med; 2015; 54(5):434-46. PubMed ID: 26429500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multi-stage drop-the-losers design for multi-arm clinical trials.
    Wason J; Stallard N; Bowden J; Jennison C
    Stat Methods Med Res; 2017 Feb; 26(1):508-524. PubMed ID: 25228636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A web application for the design of multi-arm clinical trials.
    Grayling MJ; Wason JM
    BMC Cancer; 2020 Jan; 20(1):80. PubMed ID: 32005187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II clinical trials with time-to-event endpoints: optimal two-stage designs with one-sample log-rank test.
    Kwak M; Jung SH
    Stat Med; 2014 May; 33(12):2004-16. PubMed ID: 24338995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designs for adding a treatment arm to an ongoing clinical trial.
    Bennett M; Mander AP
    Trials; 2020 Mar; 21(1):251. PubMed ID: 32143729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designs for clinical trials with time-to-event outcomes based on stopping guidelines for lack of benefit.
    Royston P; Barthel FM; Parmar MK; Choodari-Oskooei B; Isham V
    Trials; 2011 Mar; 12():81. PubMed ID: 21418571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal two-stage designs for exploratory basket trials.
    Zhou H; Liu F; Wu C; Rubin EH; Giranda VL; Chen C
    Contemp Clin Trials; 2019 Oct; 85():105807. PubMed ID: 31260789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fully order restricted multi-arm multi-stage clinical trial design.
    Kanapka L; Ivanova A
    Stat Med; 2023 Jul; 42(17):3050-3066. PubMed ID: 37190881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simulation study of outcome adaptive randomization in multi-arm clinical trials.
    Wathen JK; Thall PF
    Clin Trials; 2017 Oct; 14(5):432-440. PubMed ID: 28982263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Considerations on covariates and endpoints in multi-arm multi-stage clinical trials selecting all promising treatments.
    Jaki T; Magirr D
    Stat Med; 2013 Mar; 32(7):1150-63. PubMed ID: 23112135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factorial versus multi-arm multi-stage designs for clinical trials with multiple treatments.
    Jaki T; Vasileiou D
    Stat Med; 2017 Feb; 36(4):563-580. PubMed ID: 27804166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations for the design of small population clinical trials.
    Day S; Jonker AH; Lau LPL; Hilgers RD; Irony I; Larsson K; Roes KC; Stallard N
    Orphanet J Rare Dis; 2018 Nov; 13(1):195. PubMed ID: 30400970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory perspectives on multiplicity in adaptive design clinical trials throughout a drug development program.
    Wang SJ; Hung HM; O'Neill R
    J Biopharm Stat; 2011 Jul; 21(4):846-59. PubMed ID: 21516573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradigms for adaptive statistical information designs: practical experiences and strategies.
    Wang SJ; Hung HM; O'Neill R
    Stat Med; 2012 Nov; 31(25):3011-23. PubMed ID: 22927234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlling type I error rates in multi-arm clinical trials: A case for the false discovery rate.
    Wason JMS; Robertson DS
    Pharm Stat; 2021 Jan; 20(1):109-116. PubMed ID: 32790026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-arm multi-stage trials can improve the efficiency of finding effective treatments for stroke: a case study.
    Jaki T; Wason JMS
    BMC Cardiovasc Disord; 2018 Nov; 18(1):215. PubMed ID: 30482176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simulation optimization for Bayesian multi-arm multi-stage clinical trial with binary endpoints.
    Yu Z; Ramakrishnan V; Meinzer C
    J Biopharm Stat; 2019; 29(2):306-317. PubMed ID: 30763151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.